CYTOKINE PRODUCTION AND HEMOFILTRATION IN CHILDREN UNDERGOING CARDIOPULMONARY BYPASS

被引:129
作者
MILLAR, AB
ARMSTRONG, L
VANDERLINDEN, J
MOAT, N
EKROTH, R
WESTWICK, J
SCALLAN, M
LINCOLN, C
机构
[1] UNIV BATH,SCH POSTGRAD MED,BATH,AVON,ENGLAND
[2] UNIV BATH,SCH PHARM & PHARMACOL,BATH BA2 7AY,AVON,ENGLAND
[3] ROYAL BROMPTON NATL HEART & LUNG HOSP,LONDON,ENGLAND
关键词
D O I
10.1016/0003-4975(93)90740-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiorgan dysfunction still occurs after cardiopulmonary bypass and remains a major cause of morbidity and mortality, especially in the pediatric age group. This is consequent upon the so-called systemic inflammatory response to bypass with an increase in inflammatory mediators. Hemofiltration may be able to attenuate the effects of this response by elimination of some or all of these mediators. We undertook a prospective, randomized study to investigate the effect of hemofiltration on plasma levels of the cytokines tumor necrosis factor alpha, interleukin-8,land interleukin 6 in 18 infants and children undergoing deep hypothermic bypass. Serial plasma samples were taken before, during, and after bypass. Assay of the plasma samples revealed presence of the cytokines in a number of subjects in both groups, in some cases before operation. There were significant reductions in levels of tumor necrosis factor after hemofiltration, with no reduction noted in the group not undergoing hemofiltration. A similar difference (p<0.05) was detected in the levels of interleukin-6 between the two groups after bypass, although this was largely due to changes in 2 subjects. Interleukin-8 was detected in a small number of subjects insufficient for statistical analysis, but with higher values in the group undergoing hemofiltration. We conclude that hemofiltration has the potential to remove cytokines from the circulation, with consequent beneficial effects.
引用
收藏
页码:1499 / 1502
页数:4
相关论文
共 16 条
  • [1] NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS
    BAGGIOLINI, M
    WALZ, A
    KUNKEL, SL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) : 1045 - 1049
  • [2] USE OF EXTRACORPOREAL SUPPORTIVE TECHNIQUES AS ADDITIONAL TREATMENT FOR SEPTIC-INDUCED MULTIPLE ORGAN FAILURE PATIENTS
    BARZILAY, E
    KESSLER, D
    BERLOT, G
    GULLO, A
    GEBER, D
    BENZEEV, I
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (07) : 634 - 637
  • [3] CESKA M, 1989, CYTOKINE, V1, P136
  • [4] A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES
    ESPEVIK, T
    NISSENMEYER, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) : 99 - 105
  • [5] INTERLEUKIN-8 RELEASE AND NEUTROPHIL DEGRANULATION AFTER PEDIATRIC CARDIOPULMONARY BYPASS
    FINN, A
    NAIK, S
    KLEIN, N
    LEVINSKY, RJ
    STROBEL, S
    ELLIOTT, M
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (02) : 234 - 241
  • [6] HAEFFNERCAVAILLON N, 1989, J THORAC CARDIOV SUR, V98, P1100
  • [7] KISHIMOTO T, 1990, BLOOD, V74, P1
  • [8] MILLAR A B, 1990, Thorax, V45, P798
  • [9] MODULATION OF ENDOTHELIAL-CELL HEMOSTATIC PROPERTIES BY TUMOR-NECROSIS-FACTOR
    NAWROTH, PP
    STERN, DM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (03) : 740 - 745
  • [10] ROCKE DA, 1987, J THORAC CARDIOV SUR, V93, P832